Wharton Business Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
Wharton Business Group's AGN Position: Q3 2017 in Review
Wharton Business Group sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,049 shares — an estimated $255K sold.
Wharton Business Group first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $5.82M in Q4 2014. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.
- Wharton Business Group reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
- Wharton Business Group sold 1,049 Allergan plc shares in Q3 2017, an estimated $255K.
- Wharton Business Group first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
- Wharton Business Group's Allergan plc position peaked at $5.82M in Q4 2014.
- 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.
Based on Wharton Business Group's 13F filing for Q3 2017, filed 2 Nov 2017.